In the presented patient case, which lipid parameter is most commonly used to assess risk for coronary artery disease?

In the presented patient case, which lipid parameter is most commonly used to assess risk for coronary artery disease?

• A. LDL cholesterol
• B. HDL cholesterol
• C. Total cholesterol
• D. Triglycerides

Answer: (A)

Low-density lipoprotein cholesterol is the main lipid parameter used to assess risk for coronary artery disease because it directly gauges the number of atherogenic particles that deposit cholesterol in arterial walls, driving plaque formation. Higher LDL-C levels correlate strongly with increased CAD risk, and lowering LDL-C with therapy consistently reduces cardiovascular events, making it the most reliable single predictor and treatment target. HDL cholesterol, while inversely related to risk and indicative of reverse cholesterol transport, is not as strong a standalone predictor for CAD risk. Total cholesterol combines both protective (HDL) and atherogenic (LDL) particles, which makes it less informative for guiding risk and treatment. Triglycerides reflect metabolic state and remnant particle burden, but they do not predict CAD risk as consistently as LDL-C, especially when considered alone. In practice, LDL-C is used as the primary parameter to estimate risk and guide management, with goals adjusted based on overall risk profile.

Low-density lipoprotein cholesterol is the main lipid parameter used to assess risk for coronary artery disease because it directly gauges the number of atherogenic particles that deposit cholesterol in arterial walls, driving plaque formation. Higher LDL-C levels correlate strongly with increased CAD risk, and lowering LDL-C with therapy consistently reduces cardiovascular events, making it the most reliable single predictor and treatment target.

HDL cholesterol, while inversely related to risk and indicative of reverse cholesterol transport, is not as strong a standalone predictor for CAD risk. Total cholesterol combines both protective (HDL) and atherogenic (LDL) particles, which makes it less informative for guiding risk and treatment. Triglycerides reflect metabolic state and remnant particle burden, but they do not predict CAD risk as consistently as LDL-C, especially when considered alone.

In practice, LDL-C is used as the primary parameter to estimate risk and guide management, with goals adjusted based on overall risk profile.